CD44 and neoplasm: For example, the expression of tumour suppressor miRNA-34a is usually relatively low in various cancers, such as PC, NSCLC, and ALL, and it has been identified as a tumour suppressor with multiple targets, including CD44, PD-L1, ZEB1, and BCL-2.